The new drugs advent: clinical or economic outcomes?
نویسندگان
چکیده
منابع مشابه
The new drugs advent: clinical or economic outcomes?
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death in both men and women. Despite the introduction of newer cytotoxic agents during the last decade the survival rates still remain low. New strategies are clearly needed to improve treatment outcomes. Chemotherapy is under investigation as neoadjuvant and adjuvant strategy in early stage, and same progress has been ac...
متن کاملModeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes
Background Economic models in oncology are commonly based on the three-state partitioned survival model (PSM) distinguishing between progression-free and progressive states. However, the heterogeneity of responses observed in immuno-oncology (I-O) suggests that new approaches may be appropriate to reflect disease dynamics meaningfully. Materials and methods This study explored the impact of i...
متن کاملClinical and economic outcomes with appropriate or partial prophylaxis.
INTRODUCTION Despite the existence of evidence-based guidelines for venous thromboembolism (VTE) prevention, prophylaxis is often inappropriately prescribed. This study compared the efficacy, safety, and cost of appropriate (ACCP-recommended) prophylaxis with partial prophylaxis (not completely conforming to ACCP guidelines) in patients at-risk of VTE receiving enoxaparin or unfractionated hepa...
متن کاملClinical And Health-Economic Criteria for the Assessment of New Immune-Oncologic Drugs in Spain.
*Other members of the Scienti c Committee: Alegre EJ, Clopés A, Garrido P, Isla D, Lamas MJ, Martín M, Martín-Algarra S, Massuti B, Piulats JM 1 Facultad de Terapia Ocupacional, Logopedia y Enfermería de Talavera de la Reina. Toledo. Universidad Castilla-La Mancha, Spain. 2 Facultad de Ciencias Jurídicas y Sociales de Toledo. Universidad Castilla-La Mancha, Spain. 3 Facultad de Economía y Empre...
متن کاملThe new antiepileptic drugs: clinical applications.
In the past decade, 8 new antiepileptic drugs have been approved for use in the United States, offering many new treatment options to patients with epilepsy. With expanding use of these newer agents, primary care clinicians are challenged with understanding the roles that each new agent plays in the treatment of patients with epilepsy as well as possible interactions with other pharmacological ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2006
ISSN: 0923-7534
DOI: 10.1093/annonc/mdj934